September 25-26, 2012 - EU Pharma Regulatory Law*** (C5) - Brussels, Belgium
September 27, 2012 - Cross Winds in the Safe Harbor: Classen v. Biogen and Momenta v. Amphastar (Intellectual Property Owners Association) - 1:00 pm (ET)
September 28, 2012 - Focus on Biologics and Biosimilars (Catalyzing Collaboration Between Industry and Academia in the Life Sciences) - Hospira, Inc., Lake Forest, IL
October 2, 2012 - Single Claim Restriction Requirements: The Interplay Between 35 USC § 112 and 35 USC § 121 (American Bar Association) - 12:00 - 1:30 pm (Eastern)
October 4, 2012 - Myriad: The Gene Patent Fight Continues . . . (Technology Transfer Tactics) - 1:00 - 2:00 pm (Eastern)
October 10-11, 2012 - Maximizing Pharmaceutical Patent Lifecycles*** (ACI) - New York, NY
October 10-11, 2012 - Biotech & Pharmaceutical Patenting*** (C5) - London, UK
October 11, 2012 - 2012 Intellectual Property Continuing Legal Education Seminar (DuPont and the Widener University School of Law) - Wilmington, DE
October 22-23, 2012 - Tech Transfer Summit North America*** (Tech Transfer Summit Ltd.) - John Hopkins University, Montgomery County, MD
October 23, 2012 - Biosimilars: Draft FDA Guidance and Emerging Legal Challenges (Strafford) - 1:00 - 2:30 pm (EDT)
October 24-25, 2012 - FDA Boot Camp Devices Edition*** (American Conference Institute) - Chicago, IL
October 25-26, 2012 - Life Sciences Congress on Paragraph IV Disputes (Center for Business Intelligence) - Washington, DC
October 25-27, 2012 - AIPLA 2012 Annual Meeting (American Intellectual Property Law Association) - Washington, DC
November 28-29, 2012 - Biotech Patents*** (American Conference Institute) - Boston, MA
November 28-29, 2012 - Orphan Drugs and Rare Diseases*** (American Conference Institute) - Boston, MA
December 3-5, 2012 - Drug and Medical Device Litigation*** (American Conference Institute) - New York, NY
***Patent Docs is a media partner of this conference or CLE
Comments